Krystal Biotech, Inc. (KRYS)

288.88 +4.31 (+1.51%) USD  |  NASDAQ  |  May 06, 16:00
288.88 0.00 (0.00%) After-Hours: 20:00
More

Krystal Biotech Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Scholar Rock Holding Corp. Upgrade
Stoke Therapeutics, Inc. Upgrade
Moderna, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
TG Therapeutics, Inc. Upgrade